BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 398989)

  • 21. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance.
    Gerber JG; Payne NA; Murphy RC; Nies AS
    J Clin Invest; 1981 Mar; 67(3):632-6. PubMed ID: 7009646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
    Whittle BJ; Moncada S; Mullane K; Vane JR
    Prostaglandins; 1983 Feb; 25(2):205-23. PubMed ID: 6344147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostacyclin (PGI2) elicits reflex bradycardia in dogs: evidence for vagal mediation.
    Hintze TH; Martin EG; Messina EJ; Kaley G
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):96-100. PubMed ID: 388455
    [No Abstract]   [Full Text] [Related]  

  • 25. Renin release from filtering and nonfiltering kidneys stimulated by PGI2 and PGD2.
    Seymour AA; Davis JO; Freeman RH; DeForrest JM; Rowe BP; Williams GM
    Am J Physiol; 1979 Oct; 237(4):F285-90. PubMed ID: 386806
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse.
    Rosenblum WI; El-Sabban F
    Stroke; 1979; 10(4):399-401. PubMed ID: 388737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.
    Kubo K; Kobayashi T; Yoshimura K; Fukushima M; Handa K; Kusama S; Sakai A; Ueda G
    Jpn Circ J; 1982 Dec; 46(12):1292-304. PubMed ID: 6754986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material".
    Borda ES; Sterin-Borda L; Gimeno MF; Lazzari MA; Gimeno AL
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):79-89. PubMed ID: 6342559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
    van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes of mean arterial pressure of the rat resulting from intracerebroventricular injections of prostacyclin or 6-keto-prostaglandin F1 alpha.
    Kenney NJ
    Prostaglandins; 1983 Mar; 25(3):335-42. PubMed ID: 6346396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of epoprostenol (prostacyclin, PGI2) on cerebral blood flow in man.
    Brown MM; Pickles H
    J Neurol Neurosurg Psychiatry; 1982 Nov; 45(11):1033-6. PubMed ID: 6816907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central cardiovascular effects of prostacyclin.
    Feuerstein G; Adelberg S; Kopin IJ; Jacobowitz DM
    Neuropharmacology; 1981 Nov; 20(11):1085-90. PubMed ID: 7033813
    [No Abstract]   [Full Text] [Related]  

  • 34. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL; Blass KE; Förster W
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous administration of prostacyclin in rabbits: elimination kinetics and blood pressure response.
    Skrinska VA; Lucas FV; Chisolm GM; Hesse BL
    J Lab Clin Med; 1986 Mar; 107(3):187-93. PubMed ID: 3512745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW; Shebuski RJ
    Prostaglandins; 1980 Apr; 19(4):629-43. PubMed ID: 6992235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renal haemodynamic and excretory actions of prostacyclin (PGI2) in anaesthetized dogs [proceedings].
    Hill TW; Moncada S
    Br J Pharmacol; 1978 Mar; 62(3):413P-414P. PubMed ID: 346131
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostacyclin--antiarrhythmic or arrhythmogenic? Comparison of the effects of intravenous and intracoronary prostacyclin and ZK36374 during coronary artery occlusion and reperfusion in anaesthetised greyhounds.
    Coker SJ; Parratt JR
    J Cardiovasc Pharmacol; 1983; 5(4):557-67. PubMed ID: 6193351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.